Correlation between ITGB2 expression and clinical characterization of glioma and the prognostic significance of its methylation in low-grade glioma(LGG)

Correlation between ITGB2 expression and clinical characterization of glioma and the prognostic significance of its methylation in low-grade glioma(LGG)

IntroductionGlioma is the most common primary tumor in the brain.Integrin beta 2(ITGB2) is a member of the leukocyte integrin family (leukocyte integrin), participating in lymphocyte recycling and homing, cell adhesion, and cell surface-mediated signal transduction. However, few studies on ITGB2 in...

Full description

Bibliographic Details
Main Authors:	He Liu, Jiao Wang, Tao Luo, Zhiming Zhen, Li Liu, Yalan Zheng, Chaobin Zhang, Xiaofei Hu
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2023-01-01
Series:	Frontiers in Endocrinology
Subjects:	ITGB2 low-grade glioma immune cell methylation survival
Online Access:	https://www.frontiersin.org/articles/10.3389/fendo.2022.1106120/full

Similar Items

An automated approach for predicting glioma grade and survival of LGG patients using CNN and radiomics
by: Chenan Xu, et al.
Published: (2022-08-01)

Proposed novel classification of circumscribed Lower-Grade Gliomas (cLGG) vs. infiltrating Lower-Grade Gliomas (iLGG): Correlations of radiological features and clinical outcomes
by: Ahsan Ali Khan, et al.
Published: (2024-07-01)

Downregulation of circ_0037655 impedes glioma formation and metastasis via the regulation of miR-1229-3p/ITGB8 axis
by: Zou Wenhui, et al.
Published: (2021-05-01)

The prognostic value of ITGA and ITGB superfamily members in patients with high grade serous ovarian cancer
by: Tingting Zhu, et al.
Published: (2020-06-01)

Construction of a prognostic immune signature for lower grade glioma that can be recognized by MRI radiomics features to predict survival in LGG patients
by: Zi-zhuo Li, et al.
Published: (2021-06-01)

Comprehensive Analysis of the Expression and Prognosis for ITGBs: Identification of ITGB5 as a Biomarker of Poor Prognosis and Correlated with Immune Infiltrates in Gastric Cancer
by: Dongliang Liu, et al.
Published: (2022-02-01)

Integrative Analysis of DNA Methylation and Gene Expression Identify a Three-Gene Signature for Predicting Prognosis in Lower-Grade Gliomas
by: Wen-Jing Zeng, et al.
Published: (2018-05-01)

<it>MGMT </it>promoter methylation in gliomas-assessment by pyrosequencing and quantitative methylation-specific PCR
by: Håvik Annette, et al.
Published: (2012-03-01)

A Pan-Cancer Analysis of the Oncogenic Role of Integrin Beta4 (ITGB4) in Human Tumors
by: Huang W, et al.
Published: (2021-12-01)

Expression and prognostic analyses of ITGA11, ITGB4 and ITGB8 in human non-small cell lung cancer
by: Pancheng Wu, et al.
Published: (2019-12-01)

Perfusion and permeability MRI in glioma grading
by: Sonay Aydin, et al.
Published: (2020-01-01)

The combination of radiomics features and VASARI standard to predict glioma grade
by: Wei You, et al.
Published: (2023-03-01)

Identifying ITGB2 as a Potential Prognostic Biomarker in Ovarian Cancer
by: Chanyuan Li, et al.
Published: (2023-03-01)

CSF-Glioma: A Causal Segmentation Framework for Accurate Grading and Subregion Identification of Gliomas
by: Yao Zheng, et al.
Published: (2023-07-01)

Cognitive functioning in a cohort of high-grade glioma patients
by: Skufca Smrdel Andreja Cirila, et al.
Published: (2023-06-01)

The prognostic factors and nomogram for patients with high-grade gliomas
by: Shanqiang Qu, et al.
Published: (2021-11-01)

The relationship between IDH, P53 mutations, MGMT methylation with characteristics in high grade glioma patients
by: Duc Anh Tran, et al.
Published: (2022-07-01)

DNA Methylation-Driven Genes for Developing Survival Nomogram for Low-Grade Glioma
by: Yingyun Guo, et al.
Published: (2022-01-01)

Identification of gene expression and DNA methylation of SERPINA5 and TIMP1 as novel prognostic markers in lower-grade gliomas
by: Wen-Jing Zeng, et al.
Published: (2020-06-01)

Prognostic factor identification by analysis of the gene expression and DNA methylation data in glioma
by: Bo Wei, et al.
Published: (2020-05-01)

Preclinical Models of Low-Grade Gliomas
by: Pushan Dasgupta, et al.
Published: (2023-01-01)

Low-Grade Gliomas: Histological Subtypes, Molecular Mechanisms, and Treatment Strategies
by: Corneliu Toader, et al.
Published: (2023-12-01)

Integrated analysis of genome-wide DNA methylation and cancer-associated fibroblasts identified prognostic biomarkers and immune checkpoint blockade in lower grade gliomas
by: Jiawei Dong, et al.
Published: (2023-01-01)

Clinical significance and research progress of DNA methylation in glioma
by: YAO Ying⁃ying, et al.
Published: (2022-09-01)

Methylation and Expression of the Exercise-Related TLR1 Gene Is Associated With Low Grade Glioma Prognosis and Outcome
by: Lichun Lu, et al.
Published: (2021-11-01)

Factors Related to the Recurrence of Low-grade Gliomas
by: David Ilun Tseng Lin, et al.
Published: (2023-12-01)

Exploring the prognostic potential of m6A methylation regulators in low-grade glioma: implications for tumor microenvironment modulation
by: Honggang Wu, et al.
Published: (2024-01-01)

Analysis of DTI-Derived Tensor Metrics in Differential Diagnosis between Low-grade and High-grade Gliomas
by: Liang Jiang, et al.
Published: (2017-08-01)

Weighted correlation network analysis identifies multiple susceptibility loci for low‐grade glioma
by: Xiaodong Niu, et al.
Published: (2023-03-01)

Prognostic Factors of Low-Grade Gliomas in Adults
by: Mariana Deacu, et al.
Published: (2022-09-01)

Arachidonate lipoxygenases 5 is a novel prognostic biomarker and correlates with high tumor immune infiltration in low-grade glioma
by: Rui-han Pan, et al.
Published: (2023-01-01)

Identification and verification of the ferroptosis- and pyroptosis-associated prognostic signature for low-grade glioma
by: Jie Wang, et al.
Published: (2022-09-01)

Bevacizumab in recurrent WHO grades II–III glioma
by: Soufyan Annakib, et al.
Published: (2023-07-01)

Clinical significance of FBXO17 gene expression in high-grade glioma
by: Di Du, et al.
Published: (2018-07-01)

MicroRNAs in high-grade gliomas: What is their role?
by: Stepanović Aleksandar, et al.
Published: (2023-01-01)

Engrailed 1 overexpression as a potential prognostic marker in Lower Grade Glioma
by: Jin Zhu, et al.
Published: (2019-09-01)

Comprehensive analyses of m1A regulator-mediated modification patterns determining prognosis in lower-grade glioma (running title: m1A in LGG)
by: Kunjian Lei, et al.
Published: (2024-03-01)

Constitutive expression pattern of ITGB6 receptor gene in the air pathways of buffalo
by: RANI SINGH, et al.
Published: (2016-12-01)

Management of Patients with High-Grade Glioma
by: Simge Yukse, et al.
Published: (2014-11-01)

PD-1 (PDCD1) Promoter Methylation Is a Prognostic Factor in Patients With Diffuse Lower-Grade Gliomas Harboring Isocitrate Dehydrogenase (IDH) Mutations
by: Lea Kristin Röver, et al.
Published: (2018-02-01)